CCN1 and pulmonary hypertension: Previous studies have demonstrated that the expression of pulmonary CYR61 is increased in many inflammatory diseases, such as acute lung injury, idiopathic pulmonary fibrosis, pulmonary hypertension, and COPD (17–21, 23).